Theresa Nauth
2020–2026 OpenAlex profile ↗
Reproducibility track record
7
assessed papers
60/100
mean reproducibility
1
reproduced (C1–C2)
1
flagged
0
total citations
flag rate:
14%
(1/7)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 2
last author: 0
Topics
—
Funders
—
Frequent co-authors
Georg Rosenberger 7Verena Rickassel 4Hannah Voß 4Sophia Deden 3Thomas Mair 2Evaldas Girdauskas 2Hartmut Schlüter 2Christian Schlein 1Nina Mann 1Yskert Von Kodolitsch 1
Institutions
Universität Hamburg 7University Medical Center Hamburg-Eppendorf 7German Centre for Cardiovascular Research 2University of Duisburg-Essen 1PharmacoGenetics (China) 1University of Tübingen 1
Geography (author institutions)
DE 7US 4CN 2CA 1FR 1SK 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (7)
-
Disease-specific biomarkers of pathogenic HRAS variants in human immortalized keratinocytes.
2026 L1 No data access
-
CDKL1 variants affecting ciliary formation predispose to thoracic aortic aneurysm and dissection.
2025 L1 67/100
-
Thoracic aortic diseases: Identification of diagnostic biomarkers using proteomic analysis⚑
2025 L1 23/100 ⚑
-
Cutaneous manifestations in Costello syndrome: HRAS p.Gly12Ser affects RIN1-mediated integrin trafficking in immortalized epidermal keratinocytes.
2023 L1 66/100
-
Genetic Variants in ARHGEF6 Cause Congenital Anomalies of the Kidneys and Urinary Tract in Humans, Mice, and Frogs.
2023 L1 85/100
-
A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome.
2022 L1 No computation
-
The novel duplication HRAS c.186_206dup p.(Glu62_Arg68dup): clinical and functional aspects.
2020 L1 No computation